Your tax-deductable gift will help us to be more effective in our mission to put an end to the worldwide epidemic of Vitamin D Deficiency.

New! - Vitamin D Test

Take control of your health and monitor your own vitamin D levels!

The Vitamin D Council and ZRT Labs have partnered together to offer a discounted Vitamin D Test Kit. Now available for order over the Internet!

Search

Vitamin D On The Web

See our Vitamin D News page for all the latest vitamin D headlines from around the globe.

Our Best Vitamin D Articles page for links to informative, less-mainstream articles on vitamin D and UV exposure.

Vitamin D Research

back to research menu

Cancer

Assessment of vitamin D status and definition of a normal circulating range of 25-hydroxyvitamin D. Curr Opin Endocrinol Diabetes Obes. 2008 Dec;15(6):489–94.
RhoA-ROCK and p38MAPK-MSK1 mediate vitamin D effects on gene expression, phenotype, and Wnt pathway in colon cancer cells. Journal of Cell Biology. 2008 Nov 17. Vol. 183, No. 4, 697–710.
Dietary calcium and vitamin D intakes in childhood and throughout adulthood and mammographic density in a British birth cohort. Br J Cancer. 2008 Nov 4;99(9):1539–43.
Modification of the inverse association between dietary vitamin D intake and colorectal cancer risk by a FokI variant supports a chemoprotective action of Vitamin D intake mediated through VDR binding. Int J Cancer. 2008 Nov 1;123(9):2170–9.
Vitamin D and Prevention of Colorectal Adenoma: A Meta-analysis. Cancer Epidemiology Biomarkers & Prevention 17, 2958-2969, November 1, 2008.
Vitamin D may reduce prostate cancer metastasis by several mechanisms including blocking Stat3. Am J Pathol. 2008 Nov;173(5):1589–90.
Prevalence of Secondary Causes of Bone Loss Among Breast Cancer Patients With Osteopenia and Osteoporosis. J Clin Oncol. 2008 Oct 27.
Superagonistic fluorinated vitamin d(3) analogs stabilize helix 12 of the vitamin d receptor. Chem Biol. 2008 Oct 20;15(10):1029–34.
Circulating 25-Hydroxyvitamin D, VDR Polymorphisms, and Survival in Advanced Non-Small-Cell Lung Cancer. J Clin Oncol. 2008 Oct 20.
Randomized trial of denosumab in patients receiving adjuvant aromatase inhibitors for nonmetastatic breast cancer. J Clin Oncol. 2008 Oct 20;26(30):4875–82.
Vitamin D from dietary intake and sunlight exposure and the risk of hormone-receptor-defined breast cancer. Am J Epidemiol. 2008 Oct 15;168(8):915–24.
A randomized controlled trial of calcium plus vitamin D supplementation and risk of benign proliferative breast disease. Breast Cancer Res Treat. 2008 Oct 14.
Association of Genetic Polymorphisms in Vitamin D Receptor Gene and Susceptibility to Sporadic Prostate Cancer. Exp Biol Med (Maywood). 2008 Oct 10.
Adequate level of vitamin D is essential for maintaining good health. Postepy Hig Med Dosw (Online). 2008 Oct 9;62:502–10. In Polish.
HDAC3 impacts multiple oncogenic pathways in colon cancer cells with effects on Wnt and vitamin D signaling. Cancer Biol Ther. 2008 Oct 7;7(10).
Plasma 25-hydroxyvitamin D and premenopausal breast cancer risk in a German case-control study. Int J Cancer. 2008 Oct 6;124(1):250–255.
Chemotherapy is linked to severe vitamin D deficiency in patients with colorectal cancer. Int J Colorectal Dis. 2008 Oct 2.
Prevention of anastrozole-induced bone loss with monthly oral ibandronate during adjuvant aromatase inhibitor therapy for breast cancer. Clin Cancer Res. 2008 Oct 1;14(19):6336–42.
Dietary induction of colonic tumors in a mouse model of sporadic colon cancer. Cancer Res. 2008 Oct 1;68(19):7803–10.
Inactivation of the Human Vitamin D Receptor by Caspase-3. Endocrinology. 2008 Oct 1.
Trends in news coverage about skin cancer prevention, 1993–2006: increasingly mixed messages for the public. Aust N Z J Public Health. 2008 Oct;32(5):461–6.
Vanadium and 1, 25 (OH)2 vitamin D3 combination in inhibitions of 1,2, dimethylhydrazine-induced rat colon carcinogenesis. Biochim Biophys Acta. 2008 Oct;1780(10):1106–14.
Toxicity and antitumor activity of the vitamin D analogs PRI-1906 and PRI-1907 in combined treatment with cyclophosphamide in a mouse mammary cancer model. Cancer Chemother Pharmacol. 2008 Oct;62(5):787–97.
Calcium, dairy foods, vitamin D, and colorectal cancer risk: the Fukuoka Colorectal Cancer Study. Cancer Epidemiol Biomarkers Prev. 2008 Oct;17(10):2800–7.
Genetic variation in calcium-sensing receptor and risk for colon cancer. Cancer Epidemiol Biomarkers Prev. 2008 Oct;17(10):2755–65.
Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev. 2008 Oct;29(6):726–76.
Inactivation of the vitamin D receptor enhances susceptibility of murine skin to UV-induced tumorigenesis. J Invest Dermatol. 2008 Oct;128(10):2508–17.
UV and pigmentation: molecular mechanisms and social controversies. Pigment Cell Melanoma Res. 2008 Oct;21(5):509–16. Review.
Perspectives on obesity and sweeteners, folic acid fortification and vitamin D requirements. Fam Pract. 2008 Sep 30.
Novel Gemini vitamin D(3) analogs have potent antitumor activity. J Steroid Biochem Mol Biol. 2008 Sep 30.
Update on vitamin D and evaluation of vitamin D status. Ann Endocrinol (Paris). 2008 Sep 17. In French.
Prostate-derived Ets transcription factor as a favorable prognostic marker in ovarian cancer patients. Int J Cancer. 2008 Sep 15;123(6):1376–84.
A novel SNP in a vitamin D response element of the CYP24A1 promoter reduces protein binding, transactivation, and gene expression. J Steroid Biochem Mol Biol. 2008 Sep 6.
Risk of prostate, breast and colorectal cancer after skin cancer diagnosis. Int J Cancer. 2008 Sep 3;123(12):2899–2901.
Analysis of CYP27B1, Encoding 25-hydroxyvitamin D-1alpha-hydroxylase, as a Candidate Tumor Suppressor Gene in Primary and Severe Secondary/Tertiary Hyperparathyroidism. J Bone Miner Res. 2008 Sep 3.
Mammary epithelial cell transformation is associated with deregulation of the vitamin D pathway. J Cell Biochem. 2008 Sep 2;105(4):980–988.
Polymorphisms of the VDR gene are associated with presence of solar keratoses on the skin. Br J Dermatol. 2008 Sep;159(4):804–10.
Association of vitamin D receptor gene variants, adiposity and colon cancer. Carcinogenesis. 2008 Sep;29(9):1788–93.
Vitamin D and Sunlight: Strategies for Cancer Prevention and Other Health Benefits. Clin J Am Soc Nephrol. 2008 Sep;3(5):1548–54.
Vitamin D in health and disease. Clin J Am Soc Nephrol. 2008 Sep;3(5):1535–41.
Implementing an intervention to improve bone mineral density in survivors of childhood acute lymphoblastic leukemia: BONEII, a prospective placebo-controlled double-blind randomized interventional longitudinal study design. Contemp Clin Trials. 2008 Sep;29(5):711–9.
The origin of ovarian carcinomas: a developmental view. Gynecol Oncol. 2008 Sep;110(3):452–4.
Prospective study of combined treatment with interferon-alpha and active vitamin D3 for Japanese patients with metastatic renal cell carcinoma. Int J Urol. 2008 Sep;15(9):794–9.
Dietary supplement use among elderly, long-term cancer survivors. J Cancer Surviv. 2008 Sep;2(3):138–48.
Vitamin D From Dietary Intake and Sunlight Exposure and the Risk of Hormone-Receptor-Defined Breast Cancer. Am J Epidemiol. 2008 Aug 27.
25-Hydroxyvitamin D Levels and the Risk of Mortality in the General Population. Arch Intern Med. Vol. 168 No. 15, Aug 11/25, 2008.
Vitamin D and prostate cancer risk—a less sunny outlook? J Natl Cancer Inst. 2008 Jun 4;100(11):759–61. Review.
Serum vitamin D concentration and prostate cancer risk: a nested case-control study. J Natl Cancer Inst. 2008 Jun 4;100(11):796–804.
Vitamin D analogs: Therapeutic applications and mechanisms for selectivity. Mol Aspects Med. 2008 May 1.
Vitamin D May Reduce Prostate Cancer Metastasis by Several Mechanisms Including Blocking Stat3. American Journal of Pathology. 2008;173:1589–1590. Letter.
Solar UV-radiation, vitamin D and skin cancer surveillance in organ transplant recipients (OTRs). Adv Exp Med Biol. 2008;624:203–14. Review.
Sun exposure and cancer survival in Norway: changes in the risk of death with season of diagnosis and latitude. Adv Exp Med Biol. 2008;624:43–54.
Colon cancer: prognosis for different latitudes, age groups and seasons in Norway. J Photochem Photobiol B. 2007 Dec 14;89(2–3):148–55.
Calcium, vitamin D, and dairy product intake and prostate cancer risk: the Multiethnic Cohort Study. Am J Epidemiol. 2007 Dec 1;166(11):1259–69.
Dairy products, calcium intake, and risk of prostate cancer in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev. 2007 Dec;16(12):2623–30.
The antitumor effect of lowered doses of cytostatics combined with new analogs of vitamin D in mice. Anticancer Res. 2007 Sep–Oct;27(5A):3387–98.
Prostate cancer survival is dependent on season of diagnosis. Prostate. 2007 Sep 1;67(12):1362–70.
Plasma vitamin D and risk of colorectal cancer: the Japan Public Health Center-Based Prospective Study. Br J Cancer. 2007 Aug 6;97(3):446–51.
A nested case control study of plasma 25-hydroxyvitamin D concentrations and risk of colorectal cancer. J Natl Cancer Inst. 2007 Jul 18;99(14):1120–9.
Prospective study of serum 25(OH)-vitamin D concentration and risk of oesophageal and gastric cancers. Br J Cancer. 2007 Jul 2;97(1):123–8.
Does solar exposure, as indicated by the non-melanoma skin cancers, protect from solid cancers: vitamin D as a possible explanation. Eur J Cancer. 2007 Jul;43(11):1701–12.
Vitamin D receptor (VDR) gene polymorphisms and haplotypes, interactions with plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D, and prostate cancer risk. Prostate. 2007 Jun 15;67(9):911–23.
Sun exposure and prostate cancer risk: evidence for a protective effect of early-life exposure. Cancer Epidemiol Biomarkers Prev. 2007 Jun;16(6):1283–6.
Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr. Vol. 85, No. 6, 1586–1591, June 2007.
Intakes of Calcium and Vitamin D and Breast Cancer Risk in Women. Arch Intern Med. 2007 May 28;167:1050–1059.
Autophagy as a Mechanism of Radiation Sensitization in Breast Tumor Cells. Autophagy. 2007 May 19;3(3).
Changes in risk of death from breast cancer with season and latitude : Sun exposure and breast cancer survival in Norway. Breast Cancer Res Treat. 2007 May;102(3):323–8.
Vitamin D and breast cancer. Ugeskr Laeger. 2007 Apr 2;169(14):1299–302. In Danish.
Inhibition of lung carcinogenesis by 1alpha,25-dihydroxyvitamin D(3) and 9-cis retinoic acid in the A/J mouse model: Evidence of retinoid mitigation of vitamin D toxicity. Int J Cancer. 2007 Apr 1;120(7):1402–9.
Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of incident ovarian cancer. Cancer Epidemiol Biomarkers Prev. 2007 Apr;16(4):783–8.
Antitumor properties of diastereomeric and geometric analogs of vitamin D3. Anticancer Drugs. 2007 Apr;18(4):447–57.
A Prospective Study of Plasma Vitamin D Metabolites, Vitamin D Receptor Polymorphisms, and Prostate Cancer. PLoS Med. 2007 March 20;4(3): e103.
An ecologic study of cancer mortality rates in Spain with respect to indices of solar UVB irradiance and smoking. Int J Cancer. 2007 Mar 1;120(5):1123–8.
A meta-analysis of second cancers after a diagnosis of nonmelanoma skin cancer: Additional evidence that solar ultraviolet-B irradiance reduces the risk of internal cancers. J Steroid Biochem Mol Biol. 2007 Mar;103(3–5):668–74.
Optimal vitamin d status for colorectal cancer prevention a quantitative meta analysis. Am J Prev Med. 2007 Mar;32(3):210–6.
Seasonal and geographical variations in lung cancer prognosis in Norway. Does Vitamin D from the sun play a role? Lung Cancer. 2007 Mar;55(3):263–70.
Interaction of factors related to the metabolic syndrome and vitamin D on risk of prostate cancer. Cancer Epidemiol Biomarkers Prev. 2007 Feb;16(2):302–7.
Favourable and unfavourable effects of exposure to sunlight. Ned Tijdschr Geneeskd. 2007 Jan 13;151(2):118–22. Review In Dutch.
Mutational Analysis of the Vitamin D Receptor Does Not Support Its Candidacy as a Tumor Suppressor Gene in Parathyroid Adenomas. Journal of Clinical Endocrinology & Metabolism Vol. 91, No. 12 5019–5021.
Vitamin D—an emerging issue in skin cancer control. Implications for public health practice based on the Australian experience. Recent Results Cancer Res. 2007;174:197–204. Review.
The effect of combined treatment on head and neck human cancer cell lines with novel analogs of calcitriol and cytostatics.Oncol Res. 2007;16(11):517–25.
Role of dihydroxyvitamin D(3) and its nuclear receptor in novel directed therapies for cancer. Gen Physiol Biophys. 2006 Dec;25 (4):339–53.
Solar ultraviolet-B exposure and cancer incidence and mortality in the United States, 1993–2002. BMC Cancer. 2006 Nov 10;6:264.
The expression levels of the transcriptional regulators p300 and CtBP modulate the correlations between SNAIL, ZEB1, E-cadherin and vitamin D receptor in human colon carcinomas. Int J Cancer. 2006 Nov 1;119(9):2098–104.
Phase I study of weekly DN-101, a new formulation of calcitriol, in patients with cancer. Cancer Chemother Pharmacol. 2006 Oct 26;.
CYP24, the enzyme that catabolizes the antiproliferative agent vitamin D, is increased in lung cancer. Int J Cancer. 2006 Oct 15;119(8):1819–28.
Association of vitamin D receptor FokI polymorphism with prostate cancer risk, clinicopathological features and recurrence of prostate specific antigen after radical prostatectomy. Int J Cancer. 2006 Oct 15;119(8):1902–7.
Cancer survival is dependent on season of diagnosis and sunlight exposure. Int J Cancer. 2006 Oct 1;119(7):1530–6.
UV, latitude, and spatial trends in prostate cancer mortality: All sunlight is not the same (United States). Cancer Causes Control. 2006 Oct;17(8):1091–101.
Ultraviolet radiation, dietary vitamin D, and risk of non-Hodgkin lymphoma (United States). Cancer Causes Control. 2006 Oct;17(8):1045–52.
Changes in risk of death from breast cancer with season and latitude: Sun exposure and breast cancer survival in Norway. Breast Cancer Res Treat. 2007 May;102(3):323–8.
Vitamin D Intake and the Risk for Pancreatic Cancer in Two Cohort Studies. Cancer Epidemiology Biomarkers & Prevention Vol. 15, 1688–1695, September 2006.
Does sunlight prevent cancer? A systematic review. Eur J Cancer. 2006 Sep;42(14):2222–32. Review.
Does sunlight have a beneficial influence on certain cancers? Prog Biophys Mol Biol. 2006 Sep;92(1):132–9. Review.
Considering the potential benefits as well as adverse effects of sun exposure: Can all the potential benefits be provided by oral vitamin D supplementation? Prog Biophys Mol Biol. 2006 Sep;92(1):140–9. Review.
Vitamin D: its role in cancer prevention and treatment. Prog Biophys Mol Biol. 2006 Sep;92(1):49–59. Review.
Vitamin D physiology. Prog Biophys Mol Biol. 2006 Sep;92(1):4–8. Review.
Vitamin D deficiency: A global perspective. Arq Bras Endocrinol Metabol. 2006 Aug;50(4):640–6.
UV radiation and cancer prevention: what is the evidence? Anticancer Res. 2006 Jul–Aug;26(4A):2723–7. Review.
The association of solar ultraviolet B (UVB) with reducing risk of cancer: multifactorial ecologic analysis of geographic variation in age-adjusted cancer mortality rates. Anticancer Res. 2006 Jul–Aug;26(4A):2687–99.
The likely role of vitamin D from solar ultraviolet-B irradiance in increasing cancer survival. Anticancer Res. 2006 Jul–Aug;26(4A):2605–14.
Vitamin D metabolism in human prostate cells: implications for prostate cancer chemoprevention by vitamin D. Anticancer Res. 2006 Jul–Aug;26(4A):2567–72.
Vitamin D and cancer. Anticancer Res. 2006 Jul–Aug;26(4A):2515–24. Review.
A phase II trial of dexamethasone, vitamin D, and carboplatin in patients with hormone-refractory prostate cancer. Cancer. 2006 Jul 15;107(2):266–74.
Associations between vitamin D, vitamin D receptor gene and the androgen receptor gene with colon and rectal cancer. Int J Cancer. 2006 Jun 15;118(12):3140–6.
Cooperative antitumor effects of vitamin D(3) derivatives and rosemary preparations in a mouse model of myeloid leukemia. Int J Cancer. 2006 Jun 15;118(12):3012–21.
Phase II trial of high-dose, intermittent calcitriol (1,25 dihydroxyvitamin D3) and dexamethasone in androgen-independent prostate cancer. Cancer. 2006 May 15;106(10):2136–42.
Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst. 2006 Apr 5;98(7):451–9.
1,25-Dihydroxyvitamin D3 inhibits tumor necrosis factor-alpha-induced adhesion molecule expression in endothelial cells. Cell Biol Int. 2006 Apr;30(4):365–75.
Human Mammary Epithelial Cells Express CYP27B1 and Are Growth Inhibited by 25-Hydroxyvitamin D-3, the Major Circulating Form of Vitamin D-3. J Nutr. 2006 Apr;136(4):887–92.
Non-genomic effects of the androgen receptor and Vitamin D agonist are involved in suppressing invasive phenotype of prostate cancer cells. Steroids. 2006 Apr;71(4):304–9.
The Molecular Basis of Vitamin D Receptor and beta-Catenin Crossregulation. Mol Cell. 2006 Mar 17;21(6):799–809.
Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med. 2006 Feb 16;354(7):684–96.
The Role of Vitamin D in Cancer Prevention. Am J Public Health. 2006 Feb;96(2):252–61. Review.
A prospective study of calcium intake and incident and fatal prostate cancer. Cancer Epidemiol Biomarkers Prev. 2006 Feb;15(2):203–10.
Vitamin D analogs as anti-carcinogenic agents. Anticancer Agents Med Chem. 2006 Jan;6(1):53–71. Review.
The epidemiology of vitamin D and colorectal cancer: recent findings. Curr Opin Gastroenterol. 2006 Jan;22(1):24–9. Review.
Prostate cancer risk: the significance of differences in age related changes in serum conjugated and unconjugated steroid hormone concentrations between Arab and Caucasian men. Int Urol Nephrol. 2006;38(1):33–44.
Relationship between calcium, lactose, vitamin D, and dairy products and ovarian cancer. Nutr Cancer. 2006;56(1):22–30.
Phase I/II study of 19-nor-1alpha-25-dihydroxyvitamin D2 (paricalcitol) in advanced, androgen-insensitive prostate cancer. Clin Cancer Res. 2005 Dec 15;11(24 Pt 1):8680–5.
Upregulation of 25-hydroxyvitamin D(3)-1(alpha)-hydroxylase by butyrate in Caco-2 cells. World J Gastroenterol. 2005 Dec 7;11(45):7136–41.
UpMutational Analysis of the Vitamin D Receptor Does Not Support Its Candidacy as a Tumor Suppressor Gene in Parathyroid Adenomas. Journal of Clinical Endocrinology & Metabolism Vol. 91, No. 12 5019–5021.
Dairy, calcium, and vitamin D intake and postmenopausal breast cancer risk in the Cancer Prevention Study II Nutrition Cohort. Cancer Epidemiol Biomarkers Prev. 2005 Dec;14(12):2898–904.
Ultraviolet Radiation, Vitamin D and Risk of Prostate Cancer and Other Diseases. Photochem Photobiol. 2005 Nov–Dec;81(6):1252–60. Review.
E-cadherin and vitamin D receptor regulation by Snail and Zeb1 in colon cancer: clinicopathological correlations. Hum Mol Genet. 2005 Nov 15;14(22):3361–70.
Pharmacokinetics and tolerability of a single dose of DN-101, a new formulation of calcitriol, in patients with cancer. Clin Cancer Res. 2005 Nov 1;11(21):7794–9.
Vitamin D3 treatment for locally advanced thyroid cancer: a case report. Endocr J. 2005 Oct;52(5):613–6.
Vitamin D deficiency enhances the growth of MC-26 colon cancer xenografts in Balb/c mice. J Nutr. 2005 Oct;135(10):2350–4.
Colon cancer and solar ultraviolet B radiation and prevention and treatment of colon cancer in mice with vitamin D and its Gemini analogs. J Steroid Biochem Mol Biol. 2005 Oct;97(1–2):111–20.
The Vitamin D endocrine system of the gut—its possible role in colorectal cancer prevention. J Steroid Biochem Mol Biol. 2005 Oct;97(1–2):121–8.
Dietary recommendations to meet both endocrine and autocrine needs of Vitamin D. J Steroid Biochem Mol Biol. 2005 Oct;97(1–2):7–12. Review.
Inhibitory effect of 22-oxa-1,25-dihydroxyvitamin D3, maxacalcitol, on the proliferation of pancreatic cancer cell lines. J Steroid Biochem Mol Biol. 2005 Oct;97(1–2):173–7.
Season of diagnosis is a prognostic factor in Hodgkin's lymphoma: a possible role of sun-induced vitamin D. Br J Cancer. 2005 Sep 5;93(5):571–4.
High dose pulse calcitriol, docetaxel and estramustine for androgen independent prostate cancer: a phase I/II study. J Urol. 2005 Sep;174(3):888–92.
Vitamin D and the epidemiology of prostate cancer. Semin Dial. 2005 Jul–Aug;18(4):276–89. Review.
Benefits and requirements of vitamin D for optimal health: a review. Altern Med Rev. 2005 Jun;10(2):94–111. Review.
Dairy, calcium, and vitamin D intakes and prostate cancer risk in the National Health and Nutrition Examination Epidemiologic Follow-up Study cohort. Am J Clin Nutr. 2005 May;81(5):1147–54.
Vitamin D and calcium deficits predispose for multiple chronic diseases. Eur J Clin Invest. 2005 May;35(5):290–304. Review.
Intakes of calcium and vitamin D and risk of colorectal cancer in women. Am J Epidemiol. 2005 Apr 15;161(8):755–64.
Snail vs vitamin D receptor expression in colon cancer: therapeutics implications. British Journal of Cancer. 2005 March 15;92:985–989.
The epidemiology of vitamin D and cancer incidence and mortality: a review (United States). Cancer Causes Control. 2005 Mar;16(2):83–95. Review.
Vitamin D and the elderly. Clin Endocrinol (Oxf). 2005 Mar;62(3):265–81. Review.
Seasonal variation in the diagnosis of cutaneous melanoma and non-cutaneous malignancies: an Italian population-based study. Melanoma Res. 2005 Feb;15(1):69–72.
The association of calcium and vitamin D with risk of colorectal adenomas. J Nutr. 2005 Feb;135(2):252–9.
Cholecalciferol (vitamin D3) inhibits growth and invasion by up-regulating nuclear receptors and 25-hydroxylase (CYP27A1) in human prostate cancer cells. Clin Exp Metastasis. 2005;22(3):275–84.
Chemoprevention of prostate cancer by cholecalciferol (vitamin D3): 25-hydroxylase (CYP27A1) in human prostate epithelial cells. Clin Exp Metastasis. 2005;22(3):265–73.
Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3. FASEB. 2005;19:1067–1077.
Inhibition of proliferation and induction of apoptosis by 25-hydroxyvitamin D3-3beta-(2)-Bromoacetate, a nontoxic and vitamin D receptor-alkylating analog of 25-hydroxyvitamin D3 in prostate cancer cells. Clin Cancer Res. 2004 Dec 1;10(23):8018–27.
Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr. 2004 Dec;80(6 Suppl):1678S–88S. Review.
Sun exposure may protect against non-Hodgkin lymphoma: a case-control study. Int J Cancer. 2004 Dec 10;112(5):865–71.
The role of Vitamin D3 metabolism in prostate cancer. J Steroid Biochem Mol Biol. 2004 Nov;92(4):317–25. Review.
Genetics and biology of vitamin D receptor polymorphisms. Gene. 2004 Sep 1;338(2):143–56. Review.
Vitamin D, calcium, and mammographic breast densities. Cancer Epidemiol Biomarkers Prev. 2004 Sep;13(9):1466–72.
Plasma vitamin D metabolites and risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev. 2004 Sep;13(9):1502–8.
Toxicity and antineoplastic effect of (24R)-1,24-dihydroxyvitamin D3 (PRI-2191). Steroids. 2004 Sep;69(10):629–35.
Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and subsequent risk of prostate cancer. Cancer Causes Control. 2004 Apr;15(3):255–65.
Circulating vitamin D metabolites, polymorphism in vitamin D receptor, and colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev. 2004 Apr;13(4):546–52.
A multicountry ecologic study of risk and risk reduction factors for prostate cancer mortality. Eur Urol. 2004 Mar;45(3):271–9.
Vitamin D3 from sunlight may improve the prognosis of breast-, colon- and prostate cancer (Norway). Cancer Causes Control. 2004 Mar;15(2):149–58.
A critical review of studies on vitamin D in relation to colorectal cancer. Nutr Cancer. 2004;48(2):115–23. Review.
Serum levels of prostate-specific antigen and vitamin D in peritoneal dialysis patients. Adv Perit Dial. 2004;20:203–8.
Polymorphisms in the vitamin D receptor gene, ultraviolet radiation, and susceptibility to prostate cancer. Environ Mol Mutagen. 2004;43(2):121–7.
Vitamin D, calcium supplementation, and colorectal adenomas: results of a randomized trial. J Natl Cancer Inst. 2003 Dec 3;95(23):1765–71.
Vitamin D and prostate cancer prevention and treatment. Trends Endocrinol Metab. 2003 Nov;14(9):423–30. Review.
Vitamin D enhances caspase-dependent and -independent TNFalpha-induced breast cancer cell death: The role of reactive oxygen species and mitochondria. Int J Cancer. 2003 Aug 20;106(2):178–86.
Ultraviolet radiation: sun exposure, tanning beds, and vitamin D levels. What you need to know and how to decrease the risk of skin cancer. J Am Osteopath Assoc. 2003 Aug;103(8):371–5. Review.
Calcium, dairy products, and risk of prostate cancer in a prospective cohort of United States men. Cancer Epidemiol Biomarkers Prev. 2003 Jul;12(7):597–603.
Micronutrients and laryngeal cancer risk in Italy and Switzerland: a case-control study. Cancer Causes Control. 2003 Jun;14(5):477–84.
Susceptibility to prostate cancer: studies on interactions between UVR exposure and skin type. Carcinogenesis. 2003 Apr;24(4):711–7.
Prostate cancer risk and exposure to ultraviolet radiation: further support for the protective effect of sunlight. Cancer Lett. 2003 Mar 31;192(2):145–9.
Calcium, vitamin D, dairy products, and risk of colorectal cancer in the Cancer Prevention Study II Nutrition Cohort (United States). Cancer Causes Control. 2003 Feb;14(1):1–12.
Analysis of the vitamin D system in cervical carcinomas, breast cancer and ovarian cancer. Recent Results Cancer Res. 2003;164:239–46.
Ecologic studies of solar UVB radiation and cancer mortality rates. Recent Results Cancer Res. 2003;164:371–7. Review.
Mechanisms implicated in the growth regulatory effects of vitamin D compounds in breast cancer cells. Recent Results Cancer Res. 2003;164:99–110. Review.
Evaluation of vitamin D analogs as therapeutic agents for prostate cancer. Recent Results Cancer Res. 2003;164:273–88.
Vitamin D analogs and breast cancer. Recent Results Cancer Res. 2003;164:333–48. Review.
Vitamin D autocrine system and prostate cancer. Recent Results Cancer Res. 2003;164:223–37. Review.
Pharmacokinetics of high-dose oral calcitriol: results from a phase 1 trial of calcitriol and paclitaxel. Clin Pharmacol Ther. 2002 Dec;72(6):648–59.
Phytoestrogens regulate vitamin D metabolism in the mouse colon: relevance for colon tumor prevention and therapy. J Nutr. 2002 Nov;132(11 Suppl):3490S–3493S.
Vitamin D3 and vitamin D3 analogues as an adjunct to cancer chemo-therapy and radiotherapy. Curr Med Chem Anti-Canc Agents. 2002 Nov;2(6):683–90. Review.
Intake of dairy products, calcium, and vitamin d and risk of breast cancer. Natl Cancer Inst. 2002 Sep 4;94(17):1301–11.
Vitamin D and systemic cancer: is this relevant to malignant melanoma? Br J Dermatol. 2002 Aug;147(2):197–213. Review.
Cisplatin Potentiates 1,25-Dihydroxyvitamin D3-induced Apoptosis in Association with Increased Mitogen-activated Protein Kinase Kinase Kinase 1 (MEKK-1) Expression1. Vol. 1, 821–829, August 2002 Molecular Cancer Therapeutics.
Sunlight and mortality from breast, ovarian, colon, prostate, and non-melanoma skin cancer: a composite death certificate based case-control study. Occup Environ Med. 2002 Apr;59(4):257–62.
New clues about vitamin D functions in the nervous system. Trends Endocrinol Metab. 2002 Apr;13(3):100–5. Review.
An estimate of premature cancer mortality in the U.S. due to inadequate doses of solar ultraviolet-B radiation. Cancer. 2002 Mar 15;94(6):1867–75.
Mechanisms implicated in the growth regulatory effects of vitamin D in breast cancer. Endocr Relat Cancer. 2002 Mar;9(1):45–59. Review.
Vitamin D and vitamin D analogs in cancer treatment. Curr Drug Targets. 2002 Feb;3(1):85–94. Review.
Colonic epithelial cell proliferation decreases with increasing levels of serum 25-hydroxy vitamin D. Cancer Epidemiol Biomarkers Prev. 2002 Jan;11(1):113–9.
Antiproliferative effects of 1,25-dihydroxyvitamin D3 on breast cells: a mini review. Braz J Med Biol Res. 2002 Jan;35(1):1–9. Review.
Vitamin D-related therapies in prostate cancer. Cancer Metastasis Rev. 2002;21(2):147–58. Review.
Dietary calcium and vitamin D intake and risk of colorectal cancer: a prospective cohort study in women. Nutr Cancer. 2002;43(1):39–46.
Outcome in prostate cancer associations with skin type and polymorphism in pigmentation-related genes. Carcinogenesis. 2001 Sep;22(9):1343–7.
25-hydroxy-vitamin d metabolism in human colon cancer cells during tumor progression. Biochem Biophys Res Commun. 2001 Jul 27;285(4):1012–7.
25-hydroxyvitamin D-1alpha-hydroxylase in normal and malignant colon tissue. Lancet. 2001 May 26;357(9269):1673–4.
Vitamin D and genomic stability. Mutat Res. 2001 Apr 18;475(1–2):69–87. Review.
Vitamin D and prostate cancer. J Steroid Biochem Mol Biol. 2001 Jan–Mar;76(1–5):125–34.
Cancer chemoprevention using natural vitamin D and synthetic analogs. Annu Rev Pharmacol Toxicol. 2001;41:421–42. Review.
Prevention of N-methyl-N-nitrosourea-induced mammary carcinogenesis in rats by 1alpha-hydroxyvitamin D(5). J Natl Cancer Inst. 2000 Nov 15;92(22):1836–40.
Prostate cancer risk and prediagnostic serum 25-hydroxy vitamin D levels (Finland). Cancer Causes Control. 2000 Oct;11(9):847–52.
Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and adenomatous polyps of the distal colorectum. Cancer Epidemiol Biomarkers Prev. 2000 Oct;9(10):1059–65.
Vitamin D receptor polymorphisms are associated with altered prognosis in patients with malignant melanoma. Clin Cancer Res. 2000 Feb;6(2):498–504.
Environmental factors in nonmelanoma and melanoma skin cancer. J Epidemiol. 1999 Dec;9(6 Suppl):S102–14. Review.
Skin cancer and solar UV radiation. Eur J Cancer. 1999 Dec;35(14):2003–9. Review.
Vitamin D, calcium and prevention of breast cancer: a review. J Am Coll Nutr. 1999 Oct;18(5 Suppl):392S–397S. Review.
Association between low levels of 1,25-dihydroxyvitamin D and breast cancer risk. Public Health Nutr. 1999 Sep;2(3):283–91.
A hypothesis concerning deficiency of sunlight, cold temperature, and influenza epidemics associated with the onset of acute lymphoblastic leukemia in northern Finland. Ann Hematol. 1999 Sep;78(9):408–14.
In colorectal carcinoma patients, serum vitamin D levels vary according to stage of the carcinoma. Cancer. 1999 Aug 1;86(3):391–7.
Vitamin D and prostate cancer. Proc Soc Exp Biol Med. 1999 Jun;221(2):89–98. Review.
Vitamin D and breast cancer risk: the NHANES I Epidemiologic follow-up study, 1971–1975 to 1992. National Health and Nutrition Examination Survey. Cancer Epidemiol Biomarkers Prev. 1999 May;8(5):399–406.
Studies of calcium in food supplements in humans. Ann N Y Acad Sci. 1999;889:128–37. Review.
Calcium and vitamin D. Their potential roles in colon and breast cancer prevention. Ann N Y Acad Sci. 1999;889:107–19. Review.
Dietary influences of 1,25(OH)2 vitamin D in relation to prostate cancer: a hypothesis. Cancer Causes Control. 1998 Dec;9(6):567–82. Review.
Dairy products, calcium, phosphorous, vitamin D, and risk of prostate cancer (Sweden). Cancer Causes Control. 1998 Dec;9(6):559–66.
Human prostate cells synthesize 1,25-dihydroxyvitamin D3 from 25-hydroxyvitamin D3. Cancer Epidemiol Biomarkers Prev. 1998 May;7(5):391–5.
Vitamin D receptor polymorphisms, circulating vitamin D metabolites, and risk of prostate cancer in United States physicians. Cancer Epidemiol Biomarkers Prev. 1998 May;7(5):385–90.
Intake of selected micronutrients and risk of colorectal cancer. Cancer Epidemiol Int J Cancer. 1997 Nov 14;73(4):525–30.
Vitamin D3 analogs and their 24-oxo metabolites equally inhibit clonal proliferation of a variety of cancer cells but have differing molecular effects. J Cell Biochem. 1997 Sep 1;66(3):413–25.
Inhibition of proliferation of prostate cancer cells by a 19-nor-hexafluoride vitamin D3 analogue involves the induction of p21waf1, p27kip1 and E-cadherin. J Mol Endocrinol. 1997 Aug;19(1):15–27.
Serum levels of vitamin D metabolites and the subsequent risk of colon and rectal cancer in Finnish men. Cancer Causes Control. 1997 Jul;8(4):615–25.
Residential and occupational exposure to sunlight and mortality from non-Hodgkin's lymphoma: composite (threefold) case-control study. BMJ. 1997 May 17;314(7092):1451–5.
Vitamin D metabolism in human colon adenocarcinoma-derived Caco-2 cells: expression of 25-hydroxyvitamin D3-1alpha-hydroxylase activity and regulation of side-chain metabolism. J Steroid Biochem Mol Biol. 1997 May;62(1):21–8.
Prevention of preneoplastic mammary lesion development by a novel vitamin D analogue, 1alpha-hydroxyvitamin D5. J Natl Cancer Inst. 1997 Feb 5;89(3):212–8.
Serum 1,25-dihydroxyvitamin D may be related inversely to disease activity in breast cancer patients with bone metastases. J Clin Endocrinol Metab. 1997 Jan;82(1):118–22.
Calcium, vitamin D, and the occurrence of colorectal cancer among women. J Natl Cancer Inst. 1996 Oct 2;88(19):1375–82.
Association of prostate cancer with vitamin D receptor gene polymorphism. Cancer Res. 1996 Sep 15;56(18):4108–10.
Stable expression of the nuclear vitamin D receptor in the human prostatic carcinoma cell line JCA-1: evidence that the antiproliferative effects of 1 alpha, 25-dihydroxyvitamin D3 are mediated exclusively through the genomic signaling pathway. Endocrinology. 1996 May;137(5):1554–61.
Calcium, vitamin D, and dairy foods and the occurrence of colon cancer in men. Am J Epidemiol. 1996 May 1;143(9):907–17.
Circulating vitamin D metabolites in relation to subsequent development of prostate cancer. Cancer Epidemiol Biomarkers Prev. 1996 Feb;5(2):121–6.
Characterization of a vitamin D3-resistant MCF-7 cell line. Endocrinology. 1996 Feb;137(2):400–9.
Sunlight—can it prevent as well as cause cancer? Cancer Res. 1995 Sep 15;55(18):4014–22. Review.
Treating tumor-bearing mice with vitamin D3 diminishes tumor-induced myelopoiesis and associated immunosuppression, and reduces tumor metastasis and recurrence. Cancer Immunol Immunother. 1995 Jul;41(1):37–45.
Prostate cancer and prediagnostic levels of serum vitamin D metabolites (Maryland, United States). Cancer Causes Control. 1995 May;6(3):235–9.
Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3. Endocrinology. 1995 Jan;136(1):20–6.
Vitamin D and prostate cancer. Adv Exp Med Biol. 1995;375:53–63. Review.
Sunlight, vitamin D, and ovarian cancer mortality rates in US women. Int J Epidemiol. 1994 Dec;23(6):1133–6.
Interspecies comparative pathology of colorectal neoplasms: relevance for treatment. In Vivo. 1994 Nov–Dec;8(5):893–914.
Sun exposure and non-melanocytic skin cancer. Cancer Causes Control. 1994 Jul;5(4):367–92. Review.
Calcium, vitamin D, dairy foods, and the occurrence of colorectal adenomas among men and women in two prospective studies. Am J Epidemiol. 1994 Jan 1;139(1):16–29.
Vitamin D adequacy: a possible relationship to breast cancer. Adv Exp Med Biol. 1994;364:109–14. Review.
Vitamin D and prostate cancer: a prediagnostic study with stored sera. Cancer Epidemiol Biomarkers Prev. 1993 Sep–Oct;2(5):467–72.
Relation of calcium, vitamin D, and dairy food intake to incidence of colon cancer among older women. The Iowa Women's Health Study. Am J Epidemiol. 1993 Jun 15;137(12):1302–17. Review.
Vitamin D and prostate cancer: 1,25 dihydroxyvitamin D3 receptors and actions in human prostate cancer cell lines. Endocrinology. 1993 May;132(5):1952–60.
Beneficial effects of sun exposure on cancer mortality. Prev Med. 1993 Jan;22(1):132–40. Review.
Geographic patterns of prostate cancer mortality. Evidence for a protective effect of ultraviolet radiation. Cancer. 1992 Dec 15;70(12):2861–9.
Colorectal cancer and solar radiation. Cancer Causes Control. 1992 Jan;3(1):95–9.
Multiple sclerosis and prostate cancer: what do their similar geographies suggest? Neuroepidemiology. 1992;11(4–6):244–54.
Can colon cancer incidence and death rates be reduced with calcium and vitamin D? Am J Clin Nutr. 1991 Jul;54(1 Suppl):193S–201S. Review.
Sunlight and breast cancer incidence in the USSR. Int J Epidemiol. 1990 Dec;19(4):820–4.
Geographic variation in breast cancer mortality in the United States: a hypothesis involving exposure to solar radiation. Prev Med. 1990 Nov;19(6):614–22.
Is vitamin D deficiency a risk factor for prostate cancer? (Hypothesis). Anticancer Res. 1990 Sep–Oct;10(5A):1307–11.
Serum 25-hydroxyvitamin D and colon cancer: eight-year prospective study. Lancet. 1989 Nov 18;2(8673):1176–8.
Acid haze air pollution and breast and colon cancer mortality in 20 Canadian cities. Can J Public Health. 1989 Mar–Apr;80(2):96–100.
Possible role for vitamin D in controlling breast cancer cell proliferation. Lancet. 1989 Jan 28;1(8631):188–91.
Suppression of in vivo growth of human cancer solid tumor xenografts by 1,25-dihydroxyvitamin D3. Cancer Res. 1987 Jan 1;47(1):21–5.
Seasonality of presentation of cutaneous melanoma, squamous cell cancer and basal cell cancer in the Oxford Region. Br J Cancer. 1985 Dec;52(6):893–900.
Dietary vitamin D and calcium and risk of colorectal cancer: a 19-year prospective study in men. Lancet. 1985 Feb 9;1(8424):307–9.
Do sunlight and vitamin D reduce the likelihood of colon cancer? Int J Epidemiol. 1980 Sep;9(3):227–31.

back to research menu

Unless otherwise expressly stated, all site content licensed under a Creative Commons License.

Vitamin D Newsletter

RSS Feed

New! - Vitamin D Test

Search

Vitamin D On The Web

Cancer